These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 21585657

  • 1. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
    Weldon JE, Pastan I.
    FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
    [Abstract] [Full Text] [Related]

  • 2. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
    Weldon JE, Skarzynski M, Therres JA, Ostovitz JR, Zhou H, Kreitman RJ, Pastan I.
    Bioconjug Chem; 2015 Jun 17; 26(6):1120-8. PubMed ID: 25997032
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy.
    Dieffenbach M, Pastan I.
    Biomolecules; 2020 Jun 30; 10(7):. PubMed ID: 32630017
    [Abstract] [Full Text] [Related]

  • 4. Immunotoxins containing Pseudomonas exotoxin A: a short history.
    Pastan I.
    Cancer Immunol Immunother; 2003 May 30; 52(5):338-41. PubMed ID: 12700949
    [No Abstract] [Full Text] [Related]

  • 5. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A, Groysbeck N, Guyot L, Barret L, Nominé Y, Nguekeu-Zebaze L, Bender A, Voilquin L, Lutz T, Pallaoro N, Blocat M, Deville C, Masson M, Zuber G, Chatton B, Donzeau M.
    Bioconjug Chem; 2020 Oct 21; 31(10):2421-2430. PubMed ID: 32996763
    [Abstract] [Full Text] [Related]

  • 6. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB.
    Hum Vaccin; 2007 Oct 21; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract] [Full Text] [Related]

  • 7. Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins.
    Won J, Nam P, Lee Y, Choe M.
    Biochem Biophys Res Commun; 2009 Apr 24; 382(1):15-20. PubMed ID: 19245794
    [Abstract] [Full Text] [Related]

  • 8. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.
    Kaplan G, Lee F, Onda M, Kolyvas E, Bhardwaj G, Baker D, Pastan I.
    Toxins (Basel); 2016 Jul 25; 8(8):. PubMed ID: 27463727
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.
    Rosada RS, Moreira AP, Frantz FG, Puri RK, Rahman A, Standiford TJ, Zárate-Bladés CR, Silva CL, Hogaboam CM.
    PLoS One; 2010 Jan 15; 5(1):e8721. PubMed ID: 20090941
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation.
    Mazor R, Pastan I.
    Front Immunol; 2020 Jan 15; 11():1261. PubMed ID: 32695104
    [Abstract] [Full Text] [Related]

  • 11. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D, Pastan I.
    Ann N Y Acad Sci; 1993 Jun 23; 685():740-5. PubMed ID: 8363279
    [Abstract] [Full Text] [Related]

  • 12. Creation and anti-cancer potency in HeLa cells of a novel chimeric toxin, HMGNCIDIN, composed of HMGN2 a-helical domain and PE38 KDEL domain III.
    Xiong WB, Huang N, Feng Y, Wu Q, Wang BY.
    Chin Med J (Engl); 2008 Jan 05; 121(1):82-5. PubMed ID: 18208672
    [No Abstract] [Full Text] [Related]

  • 13. Design of a modular immunotoxin connected by polyionic adapter peptides.
    Kleinschmidt M, Rudolph R, Lilie H.
    J Mol Biol; 2003 Mar 21; 327(2):445-52. PubMed ID: 12628249
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of therapeutic recombinant immunotoxins.
    Mazor R, Onda M, Pastan I.
    Immunol Rev; 2016 Mar 21; 270(1):152-64. PubMed ID: 26864110
    [Abstract] [Full Text] [Related]

  • 15. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
    Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Barzegar A, Rahbarnia L.
    Anticancer Drugs; 2017 Mar 21; 28(3):263-270. PubMed ID: 27861173
    [Abstract] [Full Text] [Related]

  • 16. Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors.
    Singh R, Samant U, Hyland S, Chaudhari PR, Wels WS, Bandyopadhyay D.
    Mol Cancer Ther; 2007 Feb 21; 6(2):562-9. PubMed ID: 17308054
    [Abstract] [Full Text] [Related]

  • 17. A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity.
    Martin-Killias P, Stefan N, Rothschild S, Plückthun A, Zangemeister-Wittke U.
    Clin Cancer Res; 2011 Jan 01; 17(1):100-10. PubMed ID: 21075824
    [Abstract] [Full Text] [Related]

  • 18. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK, Huhn M, Thepen T, Stöcker M, Krohn R, Vogel S, Jost E, Osieka R, van de Winkel JG, Fischer R, Finnern R, Barth S.
    Cancer Res; 2003 Dec 01; 63(23):8414-9. PubMed ID: 14679004
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
    Wolf P, Elsässer-Beile U.
    Int J Med Microbiol; 2009 Mar 01; 299(3):161-76. PubMed ID: 18948059
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic and apoptotic properties of a novel nano-toxin formulation based on biologically synthesized silver nanoparticle loaded with recombinant truncated pseudomonas exotoxin A.
    Gholami N, Cohan RA, Razavi A, Bigdeli R, Dashbolaghi A, Asgary V.
    J Cell Physiol; 2020 Apr 01; 235(4):3711-3720. PubMed ID: 31578716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.